---
title: "Sinobioway Medicine (002581.SZ) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002581.SZ/norm.md"
symbol: "002581.SZ"
name: "Sinobioway Medicine"
parent: "https://longbridge.com/en/quote/002581.SZ.md"
datetime: "2026-03-04T09:45:58.335Z"
locales:
  - [en](https://longbridge.com/en/quote/002581.SZ/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002581.SZ/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002581.SZ/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/002581.SZ/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/002581.SZ/norm.md)


# Sinobioway Medicine (002581.SZ) — Financial Reports

## Income Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0023 | -0.0461 | -0.0559 | -0.2292 | 0.0673 |
| ROE | -0.32% | -6.49% | -7.73% | -30.28% | 8.56% |
| Revenue | 141.28M | 35.44M | 35.33M | 45.69M | 103.93M |
| Net income | -1.51M | -30.45M | -36.85M | -151.94M | 44.24M |
| Operating income | -37.27M | -52.52M | -44.36M | -59.46M | -6.75M |
| Gross margin | 22.23% | 54.83% | 79.93% | 44.24% | 79.00% |
| Net margin | -1.07% | -85.92% | -104.30% | -332.51% | 42.57% |
| Profit quality | - | - | - | -142.38% | -289.78% |

## Balance Sheet (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 2.21B | 2.05B | 2.17B | 2.20B | 2.30B |
| Leverage | 1.11 | 1.06 | 1.10 | 1.09 | 1.04 |
| BVPS | 2.83 | 2.83 | 2.87 | 2.92 | 3.18 |
| Turnover | 0.1143 | 0.1020 | 0.1410 | 0.1590 | 0.1594 |
| Cash & STI | 325.30M | 456.02M | 445.01M | 506.40M | 428.85M |
| Inv & Rec | 127.32M | 65.21M | 87.71M | 79.64M | 81.08M |
| LT assets | 325.51M | 280.16M | 272.71M | 274.74M | 307.14M |
| Net debt | -254.46M | -452.05M | -438.70M | -503.47M | -428.64M |

## Cash Flow Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -86.58M | -84.94M | -58.61M | 41.76M | 2.33M |
| Investing CF | -55.16M | 97.42M | -2.96M | 72.64M | 80583.00 |
| Financing CF | -3.39M | -595869.00 | - | 3.15M | -10.01M |
| Free CF | -271.91M | -17.89M | -69.09M | 59.11M | -26.39M |
| OCF coverage | -120.92% | -225.37% | -949.69% | 819.93% | 17.35% |
| Repaid & issued | 8.00M | - | - | 2.77M | - |
| CapEx | -60.26M | -37.69M | -6.17M | -5.48M | -3.42M |